Titlebook: Ciprofloxacin i.v.; Defining Its Role in Christopher Garrard (Intensive Care Director) Conference proceedings 1994 Springer-Verlag Berlin H

GERM

书目名称Ciprofloxacin i.v.影响因子(影响力)




书目名称Ciprofloxacin i.v.影响因子(影响力)学科排名




书目名称Ciprofloxacin i.v.网络公开度




书目名称Ciprofloxacin i.v.网络公开度学科排名




书目名称Ciprofloxacin i.v.被引频次




书目名称Ciprofloxacin i.v.被引频次学科排名




书目名称Ciprofloxacin i.v.年度引用




书目名称Ciprofloxacin i.v.年度引用学科排名




书目名称Ciprofloxacin i.v.读者反馈




书目名称Ciprofloxacin i.v.读者反馈学科排名

barium-study

使乳化

Fretful

cacy, safety and therapeutic use of the antibiotic substance Ciprofloxacin. Of special interest for clinicians will be the clinical outcome in patients with nosocomial pneumonia and other infections of the lower respiratory tract.978-3-642-79100-0978-3-642-79098-0

接触

foliage

foliage

A Survey of Recent Developments,The safety profile of ciprofloxacin has been established in clinical trials since 1983 [1–4]. Postmarketing experience also contributes to this knowledge [5, 6]. Recently two pharmacoepidemiological studies have supported the known safety profile of ciprofloxacin in large outpatient populations [7, 8].

thwart

终端

Ciprofloxacin in Neutropenic Host Infection,The most frequent complication of granulocytopenia is infection which, if left untreated, often leads to death. As early as 1966 a retrospective analysis conducted in patients with acute leukemia confirmed that the depth and duration of neutropenia is inversely proportional to the risk of life-threatening infection [1].

举止粗野的人